` SILO (Siloam International Hospitals Tbk PT) vs Jakarta Composite Index Comparison - Alpha Spread

SILO
vs
J
Jakarta Composite Index

Over the past 12 months, SILO has underperformed Jakarta Composite Index, delivering a return of -20% compared to the Jakarta Composite Index's +25% growth.

Stocks Performance
SILO vs Jakarta Composite Index

Loading
SILO
Jakarta Composite Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
SILO vs Jakarta Composite Index

Loading
SILO
Jakarta Composite Index
Difference
www.alphaspread.com

Performance By Year
SILO vs Jakarta Composite Index

Loading
SILO
Jakarta Composite Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Siloam International Hospitals Tbk PT vs Peers

Jakarta Composite Index
SILO
HCA
4013
IHH
THC
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Siloam International Hospitals Tbk PT
Glance View

Siloam International Hospitals Tbk PT, a pivotal entity in Indonesia's healthcare landscape, weaves its success through a network of over 40 hospitals strategically spread across the archipelago. Born from the vision of the Lippo Group, Siloam has capitalized on the growing demand for quality healthcare to become one of the largest private hospital operators in the country. As the Indonesian middle class expands, so too does its emphasis on healthcare quality and accessibility, a trend Siloam has efficiently tapped into. The company’s robust integration of healthcare services, ranging from inpatient and outpatient care to diagnostics and medical laboratories, allows it to offer comprehensive solutions that cater to various medical needs. Siloam's business model thrives on aligning itself with Indonesia's burgeoning healthcare requirements by focusing on revenue streams that span from essential healthcare services to specialized medical procedures. This diverse service range facilitates a steady flow of patients, ensuring a balanced mix of routine care and higher-margin specialized treatments. Furthermore, by leveraging cutting-edge technology and forming synergistic ties with medical professionals and institutions, Siloam enhances both its service quality and operational efficiency. As it navigates the intricate healthcare market, Siloam's sustained growth reflects its adept navigation of regulatory landscapes and its commitment to accessible, high-quality medical care for Indonesians, ultimately driving its profitability and expanding its footprint across the nation’s healthcare sector.

SILO Intrinsic Value
2 572.27 IDR
Undervaluation 3%
Intrinsic Value
Price
Back to Top